Interestingly, DHH-RHEBL1-positive patients showed higher expression of several genes known to be associated with leukemia occurrence and/or tumor progression, such as FLT3 [19], BEX1 [20], MUC4 [21] and AFAP1L2 [22] (Figure 3). This evidence concerns the gene FLT3 and neoplasm.